191 related articles for article (PubMed ID: 27444959)
1. (177) Lu-5-Fluorouracil a potential theranostic radiopharmaceutical: radiosynthesis, quality control, biodistribution, and scintigraphy.
Rasheed R; Tariq S; Naqvi SA; Gillani SJ; Rizvi FA; Sajid M; Rasheed S
J Labelled Comp Radiopharm; 2016 Aug; 59(10):398-403. PubMed ID: 27444959
[TBL] [Abstract][Full Text] [Related]
2. Studies on 177Lu-labeled methylene diphosphonate as potential bone-seeking radiopharmaceutical for bone pain palliation.
Abbasi IA
Nucl Med Biol; 2011 Apr; 38(3):417-25. PubMed ID: 21492790
[TBL] [Abstract][Full Text] [Related]
3.
Rizvi SFA; Naqvi SAR; Roohi S; Sherazi TA; Rasheed R
Mol Biol Rep; 2018 Dec; 45(6):1759-1767. PubMed ID: 30143975
[TBL] [Abstract][Full Text] [Related]
4. In vivo and in vitro evaluation of
Zhang J; Wang Z; Liu H; Cai L; Feng Y; Zhou L; Wei H; Xie Y; Chen Y
Hell J Nucl Med; 2019; 22(2):103-110. PubMed ID: 31273351
[TBL] [Abstract][Full Text] [Related]
5. Preliminary studies on (177)Lu-labeled sodium pyrophosphate (177Lu-PYP) as a potential bone-seeking radiopharmaceutical for bone pain palliation.
Abbasi IA
Nucl Med Biol; 2012 Aug; 39(6):763-9. PubMed ID: 22459337
[TBL] [Abstract][Full Text] [Related]
6. Radiosynthesis, radiochemical, and biological characterization of
Akbar MU; Bokhari TH; Ahmad MR; Zia KM; Roohi S; Ayub N; Sohaib M
J Cell Biochem; 2019 Sep; 120(9):14510-14517. PubMed ID: 30994957
[TBL] [Abstract][Full Text] [Related]
7. Tracer level radiochemistry to clinical dose preparation of (177)Lu-labeled cyclic RGD peptide dimer.
Chakraborty S; Sarma HD; Vimalnath KV; Pillai MR
Nucl Med Biol; 2013 Oct; 40(7):946-54. PubMed ID: 23850487
[TBL] [Abstract][Full Text] [Related]
8. Formulation, preclinical evaluation, and preliminary clinical investigation of an in-house freeze-dried EDTMP kit suitable for the preparation of 177Lu-EDTMP.
Das T; Sarma HD; Shinto A; Kamaleshwaran KK; Banerjee S
Cancer Biother Radiopharm; 2014 Dec; 29(10):412-21. PubMed ID: 25409337
[TBL] [Abstract][Full Text] [Related]
9. Radiolabeling, quality control, and biological characterization ofÂ
Akbar MU; Bokhari TH; Khalid M; Ahmad MR; Roohi S; Hina S; Mehmood S; Sohaib M; Jabbar T
Chem Biol Drug Des; 2017 Sep; 90(3):425-431. PubMed ID: 28152272
[TBL] [Abstract][Full Text] [Related]
10. Bulk Scale Formulation of Therapeutic Doses of Clinical Grade Ready-to-Use
Mathur A; Prashant V; Sakhare N; Chakraborty S; Vimalnath KV; Mohan RK; Arjun C; Karkhanis B; Seshan R; Basu S; Korde A; Banerjee S; Dash A; Sachdev SS
Cancer Biother Radiopharm; 2017 Sep; 32(7):266-273. PubMed ID: 28910148
[TBL] [Abstract][Full Text] [Related]
11. Preparation and preliminary studies on 177Lu-labeled hydroxyapatite particles for possible use in the therapy of liver cancer.
Chakraborty S; Das T; Sarma HD; Venkatesh M; Banerjee S
Nucl Med Biol; 2008 Jul; 35(5):589-97. PubMed ID: 18589303
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo evaluation of 177Lu- and 90Y-labeled E. coli heat-stable enterotoxin for specific targeting of uroguanylin receptors on human colon cancers.
Giblin MF; Sieckman GL; Shelton TD; Hoffman TJ; Forte LR; Volkert WA
Nucl Med Biol; 2006 May; 33(4):481-8. PubMed ID: 16720239
[TBL] [Abstract][Full Text] [Related]
13. Radiolabeling of benzylpenicillin with lutetium-177: Quality control and biodistribution study to develop theranostic infection imaging agent.
Shahzad MA; Naqvi SAR; Rasheed R; Yameen M; Anjum F; Ahmed MT; Hussain Z; Gillani SJH
Pak J Pharm Sci; 2017 Nov; 30(6(Supplementary)):2349-2354. PubMed ID: 29188768
[TBL] [Abstract][Full Text] [Related]
14. Production, quality control, biodistribution assessment and preliminary dose evaluation of (177)Lu-PDTMP as a possible bone palliative agent.
Yousefnia H; Jalilian AR; Zolghadri S; Ghannadi-Maragheh M
Nucl Med Commun; 2014 Jan; 35(1):99-107. PubMed ID: 24162837
[TBL] [Abstract][Full Text] [Related]
15. Preparation and pre-clinical study of 177Lu-labelled hydroxyapatite for application in radiation synovectomy of small joints.
Abbasi I; Ishfaq M; Sohaib M
Q J Nucl Med Mol Imaging; 2011 Aug; 55(4):458-68. PubMed ID: 21068710
[TBL] [Abstract][Full Text] [Related]
16. Preparation and pharmacological evaluation of a new radiopharmaceutical, technetium-99m-5-fluorouracil, for tumor scintigraphy.
Kumar S; Kumar Mishra A; Chhikara BS; Chuttani K; Kumar Sharma R
Hell J Nucl Med; 2008; 11(2):91-5. PubMed ID: 18815662
[TBL] [Abstract][Full Text] [Related]
17. Preparation of [
Guleria M; Das T; Amirdhanayagam J; Sarma HD; Dash A
Nucl Med Biol; 2019; 78-79():31-40. PubMed ID: 31731177
[TBL] [Abstract][Full Text] [Related]
18. Preparation and preliminary biological evaluation of 177Lu-labelled hydroxyapatite as a promising agent for radiation synovectomy of small joints.
Chakraborty S; Das T; Banerjee S; Sarma HD; Venkatesh M
Nucl Med Commun; 2006 Aug; 27(8):661-8. PubMed ID: 16829766
[TBL] [Abstract][Full Text] [Related]
19. Stability Matters: Radiochemical Stability of Therapeutic Radiopharmaceutical
Vyas M; Lim R; Fagan J; Chandrashekar R
J Nucl Med Technol; 2022 Sep; 50(3):244-247. PubMed ID: 35701217
[TBL] [Abstract][Full Text] [Related]
20. Radiosynthesis and Biodistribution of
Iqbal A; Naqvi SAR; Rasheed R; Mansha A; Ahmad M; Zahoor AF
Appl Biochem Biotechnol; 2018 May; 185(1):127-139. PubMed ID: 29098558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]